Ronald Silver News Today

StockNews.com lowered shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) from a strong-buy rating to a buy rating in a research note issued to investors on Thursday morning. Separately, Piper Sandler increased their target price on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research note on Tuesday, May 23rd. Ironwood Pharmaceuticals Stock Performance IRWD […]

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday. Separately, Piper Sandler lifted their price objective on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research report on Tuesday. Ironwood Pharmaceuticals Stock Performance Shares of NASDAQ:IRWD opened at $10.81 […]

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 17,130,000 shares, a decrease of 14.9% from the April 15th total of 20,130,000 shares. Approximately 11.3% of the company’s stock are sold short. Based on an average […]

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) issued its earnings results on Thursday. The biotechnology company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.01, Briefing.com reports. The business had revenue of $104.06 million for the quarter, compared to analyst estimates of $100.60 million. Ironwood Pharmaceuticals had a net […]

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) was the recipient of unusually large options trading activity on Thursday. Traders bought 4,553 call options on the stock. This is an increase of approximately 13,697% compared to the average volume of 33 call options. Insiders Place Their Bets In other Ironwood Pharmaceuticals news, COO Jason Rickard sold […]

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) – Analysts at Zacks Research cut their Q2 2024 earnings per share estimates for shares of Ironwood Pharmaceuticals in a research note issued on Wednesday, April 5th. Zacks Research analyst E. Bagri now anticipates that the biotechnology company will earn $0.26 per share for the quarter, down from […]

New Music New College reprises a high-voltage tribute to Mary Shelly’s tale of a modern Prometheus.

Analysts expect that Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) will announce sales of $101.44 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Ironwood Pharmaceuticals’ earnings. The lowest sales estimate is $96.01 million and the highest is $105.50 million. Ironwood Pharmaceuticals reported sales of $104.03 million during […]

Brokerages expect that Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) will report earnings of $0.31 per share for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Ironwood Pharmaceuticals’ earnings, with estimates ranging from $0.28 to $0.35. Ironwood Pharmaceuticals posted earnings of $0.34 per share in the same quarter last year, […]

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) released its earnings results on Thursday. The biotechnology company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.10), MarketWatch Earnings reports. Ironwood Pharmaceuticals had a return on equity of 33.93% and a net margin of 124.83%. The company had revenue of $97.53 million during […]